1. BeckfordAP, KaschulaRO, StephenC (1985) Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 68: 858–863.
2. AkramuzzamanSM, CuttsFT, WheelerJG, HossainMJ (2000) Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 151: 723–735.
3. ShanksGD, LeeSE, HowardA, BrundageJF (2011) Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911. Am J Epidemiol 173: 1211–1222.
4. Von PirquetCE (1908) Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 34: 1297–1300.
5. TamashiroVG, PerezHH, GriffinDE (1987) Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J 6: 451–454.
6. LisseI, SambB, WhittleH, JensenH, SoumareM, et al. (1998) Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis 30: 17–21.
7. RyonJJ, MossWJ, MonzeM, GriffinDE (2002) Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin Diagn Lab Immunol 9: 994–1003.
8. Premenko-LanierM, RotaPA, RhodesGH, BelliniWJ, McChesneyMB (2004) Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 189: 2064–2071.
9. BankampB, HodgeG, McChesneyMB, BelliniWJ, RotaPA (2008) Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 373: 39–50.
10. HirschRL, GriffinDE, JohnsonRT, CooperSJ, Lindo de SorianoI, et al. (1984) Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31: 1–12.
11. WardBJ, JohnsonRT, VaisbergA, JaureguiE, GriffinDE (1991) Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 61: 236–248.
12. GriffinDE, WardBJ (1993) Differential CD4 T cell activation in measles. J Infect Dis 168: 275–281.
13. Fugier-VivierI, Servet-DelpratC, RivaillerP, RissoanM-C, LiuY-J, et al. (1997) Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186: 813–823.
14. GrosjeanI, CauxC, BellaC, BergerI, WildF, et al. (1997) Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med 186: 801–812.
15. SchnorrJ-J, XanthakosS, KeikavoussiP, KampgenE, Ter MeulenV, et al. (1997) Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immmunosuppression. Proc Natl Acad Sci U S A 94: 5326–5331.
16. GriffinDE, WardBJ, JaureguiE, JohnsonRT, VaisbergA (1989) Immune activation in measles. N Engl J Med 320: 1667–1672.
17. FerreiraCS, FrenzkeM, LeonardVH, WelsteadGG, RichardsonCD, et al. (2010) Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol 84: 3033–3042.
18. LemonK, De VriesRD, MesmanAW, McQuaidS, Van AmerongenG, et al. (2011) Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7: e1001263.
19. De VriesRD, MesmanAW, GeijtenbeekTBH, DuprexWP, De SwartRL (2012) The pathogenesis of measles. Curr Opin Virol In press: DOI 10.1016/j.coviro.2012.03.005..
20. TatsuoH, OnoN, YanagiY (2001) Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 75: 5842–5850.
21. NoyceRS, BondreDG, HaMN, LinLT, SissonG, et al. (2011) Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 7: e1002240.
22. MühlebachMD, MateoM, SinnPL, PruferS, UhligKM, et al. (2011) Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480: 530–3.
23. RacanielloV (2011) An exit strategy for measles virus. Science 334: 1650–1651.
24. SullivanJL, BarryDW, LucasSJ, AlbrechtP (1975) Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med 142: 773–784.
25. HuddlestoneJR, LampertPW, OldstoneMBA (1980) Virus-lymphocyte interactions: infection of Tg and Tm subsets by measles virus. Clin Immunol Immunopathol 15: 502–509.
26. ForthalDN, AarnaesS, BlandingJ, De la MazaL, TillesJG (1992) Degree and length of viremia in adults with measles. J Infect Dis 166: 421–424.
27. De SwartRL, LudlowM, De WitteL, YanagiY, Van AmerongenG, et al. (2007) Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: e178.
28. CondackC, GrivelJ-C, DevauxP, MargolisL, CattaneoR (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196: 541–549.
29. De SwartRL (2009) Measles studies in the macaque model. Curr Top Microbiol Immunol 330: 55–72.
30. De VriesRD, LemonK, LudlowM, McQuaidS, YükselS, et al. (2010) In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol 84: 4714–4724.
31. CocksBG, ChangCC, CarballidoJM, YsselH, De VriesJE, et al. (1995) A novel receptor involved in T-cell activation. Nature 376: 260–263.
32. De SalortJ, SintesJ, LlinasL, Matesanz-IsabelJ, EngelP (2011) Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells. Immunol Lett 134: 129–136.
33. McChesneyMB, MillerCJ, RotaPA, ZhuY, AntipaL, et al. (1997) Experimental measles I. Pathogenesis in the normal and the immunized host. Virology 233: 74–84.
34. WarthinAS (1931) Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 11: 864–874.
35. De VriesRD, YükselS, OsterhausADME, De SwartRL (2010) Specific CD8+ T-lymphocytes control dissemination of measles virus. Eur J Immunol 40: 388–395.
36. Van BinnendijkRS, PoelenMCM, KuijpersKC, OsterhausADME, UytdeHaagFGCM (1990) The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. J Immunol 144: 2394–2399.
37. MongkolsapayaJ, JayeA, CallanMFC, MagnusenAF, McMichaelAJ, et al. (1999) Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 73: 67–71.
38. MoussallemTM, GuedesF, FernandesER, PagliariC, LancellottiCLP, et al. (2007) Lung involvement in childhood measles: severe immune dysfunction revealed by quantitative immunohistochemistry. Hum Pathol 38: 1239–1247.
39. SallustoF, LenigD, ForsterR, LippM, LanzavecchiaA (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708–712.
40. Schneider-SchauliesS, Schneider-SchauliesJ (2009) Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 330: 243–269.
41. HahmB (2009) Hostile communication of measles virus with host innate immunity and dendritic cells. Curr Top Microbiol Immunol 330: 271–287.
42. GriffinDE (2010) Measles virus-induced suppression of immune responses. Immunol Rev 236: 176–189.
43. SteineurMP, GrosjeanI, BellaC, KaiserlianD (1998) Langerhans cells are susceptible to measles virus infection and actively suppress T cell proliferation. Eur J Dermatol 8: 413–420.
44. Servet-DelpratC, VidalainP-O, BausingerH, ManieS, Le DeistF, et al. (2000) Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol 164: 1753–1760.
45. VidalainP-O, AzocarO, Rabourdin-CombeC, Servet-DelpratC (2001) Measles virus-infected dendritic cells develop immunosuppressive and cytotoxic activities. Immunobiol 204: 629–638.
46. De WitteL, De VriesRD, Van der VlistM, YükselS, LitjensM, et al. (2008) DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 4: e1000049.
47. Van der VlistM, De WitteL, De VriesRD, LitjensM, De JongMAWP, et al. (2011) Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4(+) T-cells but are incapable of cross-presentation. Eur J Immunol 41: 2619–2631.
48. AvotaE, AvotsA, NiewieskS, KaneLP, BommhardtU, et al. (2001) Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med 7: 725–731.
49. McCulloughB, KrakowkaS, KoestnerA (1974) Experimental canine distemper virus-induced lymphoid depletion. Am J Pathol 74: 155–170.
50. von MesslingV, SpringfeldC, DevauxP, CattaneoR (2003) A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77: 12579–12591.
51. BeinekeA, PuffC, SeehusenF, BaumgartnerW (2009) Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 127: 1–18.
52. De SwartRL, VosHW, UytdeHaagFGCM, OsterhausADME, Van BinnendijkRS (1998) Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. J Virol Methods 71: 35–44.
53. SimpanenE, vanER, IsomakiH (1977) Remission of juvenile rheumatoid arthritis (Still's disease) after measles. Lancet 2: 987–988.
54. YoshiokaK, MiyataH, MakiS (1981) Transient remission of juvenile rheumatoid arthritis after measles. Acta Paediatr Scand 70: 419–420.
55. LinCY, LinMT, HsiehYL, TsaoLY (1988) Transient disappearance of immunologic disorders and remission after intercurrent measles infections in children with chronic idiopathic thrombocytopenic purpura. J Clin Immunol 8: 207–213.
56. MossWJ, ScottS, NdhlovuZ, MonzeM, CuttsFT, et al. (2009) Suppression of human immunodeficiency virus type 1 viral load during acute measles. Pediatr Infect Dis J 28: 63–65.
57. RuelTD, AchanJ, GasasiraAF, CharleboisED, MehbratuT, et al. (2008) HIV RNA suppression among HIV-infected Ugandan children with measles. J Acquir Immune Defic Syndr 48: 225–227.
58. KretschmerR, JanewayCA, RosenFS (1968) Immunologic amnesia. Study of an 11-year-old girl with recurrent severe infections associated with dysgammaglobulinemia, lymphopenia and lymphocytotoxic antibody, resulting in loss of immunologic memory. Pediat Res 2: 7–16.
59. LangermansJA, AndersenP, van SoolingenD, VervenneRA, FrostPA, et al. (2001) Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A 98: 11497–11502.
60. NguyenDT, De WitteL, LudlowM, YükselS, WiesmullerK-H, et al. (2010) The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation. PLoS Pathog 6: e1001049.